FDA Approved: * September 9, 2009 Pharm Company: *PAR PHARM Category:Diabetes
Nateglinide (INN, trade name Starlix) is a drug for the treatment of type 2 diabetes. Nateglinide was developed by Ajinomoto, a Japanese company and sold by the Swiss pharmaceutical company Novartis.
Nateglinide belongs to the meglitinide class of blood glucose-lowering drugs.
3 Comparisons with other drugs for type 2 diabetes
5 See also
7 External links
Nateglinide lowers blood glucose by stimulating the re...
* May have multiple approval dates, manufacturers, or labelers. 4 Discussions